CD22 associates with the human surface IgM-B-cell antigen receptor complex
C Leprince1, K E Draves, R L Geahlen
1Department of Microbiology, University of Washington, Seattle 98195.
Insights
The B-cell molecule CD22 modulates B-cell receptor (BCR) signaling. CD22 is rapidly phosphorylated and associates with the sIgM-BCR complex, indicating its role as a signaling partner.
Area of Science:
- Immunology
- Cell Signaling
- Molecular Biology
Background:
- The B-cell surface molecule CD22 regulates signaling pathways initiated by the B-cell receptor (BCR).
- Understanding the molecular basis of CD22 interaction with the BCR complex is crucial for deciphering B-cell activation and function.
Purpose of the Study:
- To investigate the interaction between CD22 and the human surface IgM (sIgM)-BCR complex.
- To identify the molecular components and signaling events involved in CD22-mediated modulation of BCR signaling.
Main Methods:
- B-cell lysis in digitonin followed by coimmunoprecipitation.
- In vitro kinase assays to detect phosphorylation of CD22.
- Immunoblot analysis using specific antibodies to identify protein components.
Main Results:
- CD22 coimmunoprecipitated a kinase activity that phosphorylated CD22 on tyrosine residues.
- Phosphorylated CD22 was found within the sIgM-BCR complex, alongside Ig alpha/mb-1, Ig beta/B29, and PTK72.
- Rapid and significant phosphorylation of CD22 upon sIgM cross-linking was observed.
Conclusions:
- CD22 is a key signaling partner within the sIgM-BCR complex.
- The phosphorylation of CD22 is a critical event in its modulation of BCR signaling.
- CD22's ARHI motif suggests a role in antigen recognition pathways.
Abstract:
The B-cell surface molecule CD22, when cross-linked, modulates signaling through the surface IgM (sIgM)-B-cell receptor (BCR) complex. Here we analyzed the basis of this interaction between CD22 and the human sIgM complex. After lysis of B cells or B-cell lines in digitonin, CD22 coimmunoprecipitated a kinase activity that in vitro-phosphorylated two polypeptides of 150 and 130 kDa on tyrosine residues. By immunoblot analysis with a rabbit anti-serum specific for a synthetic peptide of CD22, we found these proteins to be CD22 itself. Furthermore, the phosphorylated 150-kDa CD22 was found in the sIgM-BCR complex maintained by digitonin, along with Ig alpha/mb-1, Ig beta/B29, and a 75-kDa polypeptide precipitated by an antiserum specific to protein-tyrosine kinase PTK72. CD22 is likely to be an important signaling partner in the sIgM-BCR complex since it is very rapidly and strikingly phosphorylated after sIgM is cross-linked and since it contains the antigen recognition homology I (ARHI) motif, present in other antigen receptor molecules.
Related Concept Videos
Cell-mediated Immune Responses
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...


